Oaktree Fund Advisors, LLC
Long book
$56.5M
Q1 2026
Positions
12
Top-10 weight
99%
concentration
Last quarter
-7.5%
SPY +14.8%
Turnover
47%
of book per quarter
Strategy in plain words
auto-generated from filingsOaktree Fund Advisors, LLC is a concentrated fundamental stock-picker, running a $56.5M US long book across 12 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: ANGLOGOLD ASHANTI PLC, PETROLEO BRASILEIRO-SPON ADR, BARRICK MINING CORP, ITAU UNIBANCO H-SPON PRF ADR, YPF S.A.-SPONSORED ADR.
Over the last 9 quarters its long book ran on average 0.7pp per quarter behind the S&P 500, beating the index in 5 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-3.3%
Q2 2024
+11.9%
Q3 2024
-9.6%
Q4 2024
+12.1%
Q1 2025
+6.4%
Q2 2025
+16.2%
Q3 2025
+8.7%
Q4 2025
-0.9%
Q1 2026
-7.5%
Sector allocation
Materials 87%
Financials 12%
Healthcare 1%
Long book by quarter
What does Oaktree Fund own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| AU ANGLOGOLD ASHANTI PLC | Materials | 153.4K | $14.9M | 26.4% | Held |
| B BARRICK MINING CORP | Materials | 178.2K | $7.3M | 12.9% | Held |
| FCX FREEPORT-MCMORAN INC | Materials | 75.0K | $4.4M | 7.8% | Held |
| XP XP INC - CLASS A | Financials | 199.5K | $3.8M | 6.7% | Held |
| ALVO ALVOTECH SA | Healthcare | 217.7K | $264K | 0.5% | Held |
| BTAI BIOXCEL THERAPEUTICS INC | Healthcare | 42.9K | $58K | 0.1% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR/ARESTATEMENT | May 20, 2026 | 14 | $56.9M | canonical | SEC ↗ |
| Q1 2026 | 13F-HR | May 15, 2026 | 14 | $56.9M | SEC ↗ | |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 17 | $54.0M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 18 | $54.3M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 13, 2025 | 46 | $57.6M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 50 | $68.8M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 12, 2025 | 47 | $59.6M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 48 | $88.6M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 13, 2024 | 46 | $106.5M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 59 | $111.3M | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP